A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Anemia
Interventions: DRUG: Epoetin Beta
Sponsor: Hoffmann-La Roche